CD163 and sickle cell disease: CD163 prevented hepatobiliary injury in sickle cell disease by means of inhibiting oxidative stress, inflammation, and thrombosis [26,27]; and the reducing PEX14 impaired peroxisomes and caused liver oxidative stress [28].